Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective

Vladimir Volloch, Sophia Rits‐Volloch

View at source ↗PDF ↗Article44 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.3233/jad-230164
Published
May 16, 2023
Venue
Journal of Alzheimer s Disease
DOI
10.3233/jad-230164
PubMed
37212119
Categories
Alzheimer's disease research and treatments
License
cc-by-nc
Provenance
openalex

Topics